These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 17713457)
41. Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE. Flatt E; McLin VA; Braissant O; Pierzchala K; Mastromarino P; Mitrea SO; Sessa D; Gruetter R; Cudalbu C Sci Rep; 2021 Sep; 11(1):17988. PubMed ID: 34504135 [TBL] [Abstract][Full Text] [Related]
42. Neomycin should not be used to treat hepatic encephalopathy. Curioso WH; Monkemuller KE BMJ; 2001 Jul; 323(7306):233. PubMed ID: 11496883 [No Abstract] [Full Text] [Related]
43. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Mullen KD Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():11-6. PubMed ID: 17295847 [TBL] [Abstract][Full Text] [Related]
44. Observations on antibiotics in the treatment of hepatic coma and on factors contributing to prognosis. STORMONT JM; MACKIE JE; DAVIDSON CS N Engl J Med; 1958 Dec; 259(24):1145-50. PubMed ID: 13613480 [No Abstract] [Full Text] [Related]
45. Is oral L-acyl-carnitine an effective therapy for hepatic encephalopathy? Review of the literature. Shores NJ; Keeffe EB Dig Dis Sci; 2008 Sep; 53(9):2330-3. PubMed ID: 18270833 [TBL] [Abstract][Full Text] [Related]
47. [Lactulose therapy of the hepatoportal Encephalopathy]. Strohmeyer G Dtsch Med Wochenschr; 1970 Jul; 95(30):1580. PubMed ID: 5431974 [No Abstract] [Full Text] [Related]
48. Flumazenil in the treatment of hepatic encephalopathy. Howard CD; Seifert CF Ann Pharmacother; 1993 Jan; 27(1):46-8. PubMed ID: 8431621 [No Abstract] [Full Text] [Related]
50. Placebo controlled treatment trials in hepatic encephalopathy are feasible and ethical. Ghanta RK; Mullen KD Hepatology; 2005 Nov; 42(5):1206-7. PubMed ID: 16250042 [No Abstract] [Full Text] [Related]
51. Review: lactulose or lactitol may improve hepatic encephalopathy but may be less effective than antibiotics. Korula J ACP J Club; 2004; 141(3):59. PubMed ID: 15518443 [No Abstract] [Full Text] [Related]
52. The antibiotics as an adjunct in the treatment of otolaryngologic diseases. McMAHON BJ Trans Am Laryngol Rhinol Otol Soc; 1954; 4(58th Meeting):186-97. PubMed ID: 14373810 [No Abstract] [Full Text] [Related]
54. Rifaximin in hepatic encephalopathy: more than just a non-absorbable antibiotic? Jalan R J Hepatol; 2010 Sep; 53(3):580-2. PubMed ID: 20561708 [No Abstract] [Full Text] [Related]
55. [Rifaximin treatment in hepatic encephalopathy]. Gundling F; Schepp W Z Gastroenterol; 2011 Sep; 49(9):1345-6. PubMed ID: 21887667 [No Abstract] [Full Text] [Related]
56. Gut instinct: rifaximin for the prevention of hepatic encephalopathy. Siddique A; Kowdley K Hepatology; 2010 Aug; 52(2):792-4. PubMed ID: 20683970 [No Abstract] [Full Text] [Related]
57. Rifaximin in hepatic encephalopathy: is an ounce of prevention worth a pretty penny? Leise MD; Kim WR Gastroenterology; 2010 Oct; 139(4):1416-8. PubMed ID: 20736020 [No Abstract] [Full Text] [Related]
58. Hepatic Encephalopathy in the 21st Century: Still an Emerging Topic. Ridola L; Riggio O J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33467479 [TBL] [Abstract][Full Text] [Related]